AGENERASE
AGENERASE
Discontinued
DIN Number
02243541
Drug Class
Human
Market Date
Mar 21, 2001
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243541
AIG Number0143241001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AE05 AMPRENAVIR
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:18.08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
AMPRENAVIRActive
Strength: 50 MG
Monograph: AMPRENAVIR